Cardioprotective Effects of KR-30450, a Novel K^+_<ATP> Opener, and Its Major Metabolite KR-30818 on Isolated Rat Hearts
スポンサーリンク
概要
- 論文の詳細を見る
The cardiac effects of KR-30450 ((-)-(2R)-2-([1, 3]-dioxolan-2-yl)-2-methyl-4-(2-oxopyrrolidin-1-yl)-6-nitro-2H-1-benzopyran), a newly synthesized potassium channel activator, and its major metabolite KR-30818 ((-)-(2R)-2-hydroxymethyl-2-methyl-4-(2-oxopyrrolidin-1-yl)-6-nitro-2H-1-benzopyran) were compared with those of lemakalim, a prototype of this class, in isolated globally ischemic rat hearts. KR-30450 and KR-30818 significantly improved reperfusion cardiac function (LVDP, left ventricular developed pressure; double product, LVDP×heart rate/1000), their potency being 5.2-fold and 0.7-fold greater than lemakalim (ED50 for recovering predrug double product: 0.10, 0.80 and 0.54 μM, respectively). KR-30450 and KR-30818 significantly attenuated reperfusion contracture and lactate dehydrogenase release with potency greater than and equal to lemakalim, respectively. They significantly increased time to contracture (TTC) during ischemia in a dose-dependent manner with a greater potency than lemakalim (EC25 for increasing TTC: 1.2, 2.1 and 3.2 μM, respectively). The protective effects of three compounds on the measured parameters were reversed by glyburide, a selective K+ATP blocker. In non-ischemic hearts, KR-30450 and lemakalim exerted weak negative inotropism at high concentrations and KR-30818 had no effects, whereas the three compounds significantly increased coronary flow at doses studied. Glyburide completely reversed preischemic cardiodepressant effects of these compounds but not their effects on coronary flow. In conclusion, KR-30450, a recently developed K+ATP opener, exerted more potent cardioprotective effects than lemakalim, and its major metabolite KR-30818 may play a significant role in its action in vivo.
- 社団法人 日本薬理学会の論文
著者
-
Moon Chang-hyun
Department Of Physiology Ajou University School Of Medicine
-
Moon C‐h
Ajou Univ. Suwon Kor
-
Yoo Sung-eun
Medical Science Division Korea Research Institute Of Chemical Technology
-
Yoo S‐e
Korea Res. Inst. Of Chemical Technol. Daejon Kor
-
Cho Tai-soon
College Of Pharmacy Sung Kyun Kwan University
-
Shin Hwa-sup
Department Of Applied Biochemistry Division Of Life Science College Of Biomedical And Health Science
-
Shin Hwa-sup
Screening And Toxicology Research Center Korea Research Institute Of Chemical Technology
-
JUNG Yi-Sook
Screening and Toxicology Research Center, Korea Research Institute of Chemical Technology
-
YOO Sung-Eun
Bio-organic Division, Korea Research Institute of Chemical Technology
-
Jung Yi-sook
Department Of Physiology Ajou University School Of Medicine
関連論文
- Role of PKC-δ during Hypoxia in Heart-Derived H9c2 Cells
- High-Glucose Induced Protective Effect against Hypoxic Injury Is Associated with Maintenance of Mitochondrial Membrane Potential
- KR-31466, a Benzopyranylindol Analog, Attenuates Hypoxic Injury Through Mitochondrial K_ATP Channel and Protein Kinase C Activation in Heart-Derived H9c2 Cells
- Protein Kinase C Inhibitors Attenuate Protective Effect of High Glucose against Hypoxic Injury in H9c2 Cardiac Cells
- Cadmium Stimulates the Expression of Vascular Cell Adhesion Molecule-1 (VCAM-1) via p38 Mitogen-Activated Protein Kinase (MAPK) and JNK Activation in Cerebrovascular Endothelial Cells
- Protein Kinase C Inhibitors Abolish the Increased Resistance of Diabetic Rat Heart to Ischemia-Reperfusion Injury
- KR-31761, a Novel K^+_-Channel Opener, Exerts Cardioprotective Effects by Opening Both Mitochondrial K^+_ and Sarcolemmal K^+_ Channels in Rat Models of Ischemia/Reperfusion-Induced Heart Injury
- Effects of [5-(2-Methoxy-5-fluorophenyl)furan-2-ylcarbonyl]guanidine (KR-32560), a Novel Sodium/Hydrogen Exchanger-1 Inhibitor, on Myocardial Infarct Size and Ventricular Arrhythmias in a Rat Model of Ischemia/Reperfusion Heart Injury
- N-Nitrosocarbofuran Induces Apoptosis in Mouse Brain Microvascular Endothelial Cells (bEnd.3)
- Cardioprotective Effects of KR-30450, a Novel K^+_ Opener, and Its Major Metabolite KR-30818 on Isolated Rat Hearts
- Pharmacological Characterization of Vasorelaxant Effects of BMS-180448, a Novel Cardioselective ATP-Sensitive Potassium Channel Opener, in Rat Aorta
- Identification of Caspase-Independent PKCε-JNK/p38 MAPK Signaling Module in Response to Metabolic Inhibition in H9c2 Cells
- KR-31466, a Benzopyranylindol Analog, Attenuates Hypoxic Injury Through Mitochondrial K_ATP Channel and Protein Kinase C Activation in Heart-Derived H9c2 Cells